SEC Form 4 · accession 0000899243-17-018765
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth A Tasker
Officer — General Counsel
Period of report
Jul 21, 2017
Accepted (ET)
Jul 24, 2017 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 21, 2017 | A | 8,916 | $0.00 | A | 17,833 | D | |
| Common Stock | holding | — | — | — | 6,756 | I | 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares from a grant of performance-based restricted stock on July 22, 2016. Upon the determination by the Compensation Committee of our Board of Directors, such shares vested on July 21, 2017. The number of shares in column 5 represents a net amount of shares issued to the reporting person after the issuer withheld 4,284 shares in order to satisfy the reporting person's income tax withholding obligation.